antimicrobial peptides: diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo
Clicks: 269
ID: 197324
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
3.9
/100
13 views
13 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Antibiotic resistance is projected as one of the greatest threats to human health in the future and hence alternatives are being explored to combat resistance. Antimicrobial peptides (AMPs) have shown great promise, because use of AMPs leads bacteria to develop no or low resistance. In this review, we discuss the diversity, history and the various mechanisms of action of AMPs. Although many AMPs have reached clinical trials, to date not many have been approved by the US Food and Drug Administration (FDA) due to issues with toxicity, protease cleavage and short half-life. Some of the recent strategies developed to improve the activity and biocompatibility of AMPs, such as chemical modifications and the use of delivery systems, are also reviewed in this article.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (122 words).
Try re-searching for a better abstract.
| Reference Key |
kumar2018biomoleculesantimicrobial
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Prashant Kumar;Jayachandran N. Kizhakkedathu;Suzana K. Straus |
| Journal | international journal of middle east studies |
| Year | 2018 |
| DOI |
10.3390/biom8010004
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.